Clinical trial
Outpatient Use of Ivermectin in COVID-19
NCT04530474 is registered in ClinicalTrials.gov with Temple University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Outpatient Use of Ivermectin in COVID-19
- Lead sponsor
- Temple University
- Phase
- Phase 3
- Overall status
- Withdrawn
- Start date
- April 1, 2021
- Completion date
- June 30, 2021
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid19